LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 308 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $289,000 | -15.0% | 2,295 | -8.5% | 0.07% | -25.3% |
| Q4 2018 | $340,000 | -65.1% | 2,509 | -29.3% | 0.10% | -59.9% |
| Q3 2018 | $974,000 | +33.2% | 3,548 | +0.5% | 0.25% | +22.3% |
| Q2 2018 | $731,000 | +31.5% | 3,529 | +4.9% | 0.20% | +26.2% |
| Q1 2018 | $556,000 | +36.9% | 3,365 | +13.7% | 0.16% | +32.2% |
| Q4 2017 | $406,000 | +16.7% | 2,960 | +15.8% | 0.12% | +6.1% |
| Q3 2017 | $348,000 | +32.8% | 2,556 | +18.5% | 0.11% | +28.1% |
| Q2 2017 | $262,000 | +5.6% | 2,157 | -8.1% | 0.09% | +1.1% |
| Q1 2017 | $248,000 | +2.9% | 2,347 | -1.1% | 0.09% | -3.3% |
| Q4 2016 | $241,000 | -4.0% | 2,372 | -3.5% | 0.09% | -9.0% |
| Q3 2016 | $251,000 | -9.7% | 2,458 | +5.6% | 0.10% | -10.7% |
| Q2 2016 | $278,000 | – | 2,327 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |